Open access
Jul 2026
SP-3 Ameliorates Established Cyclophosphamide-Induced Liver Injury and Is Associated with PPAR-Related Transcriptional and Lipid-Metabolic Changes
Data support the post-injury therapeutic efficacy of SP-3 against CP-induced liver injury, highlighting its potential role in modulating PPARα-related lipid metabolic homeostasis as a promising strategy for drug-induced liver injury management.
Cai Ke, Peng Wang, Yanting Bai et al.
· International Journal of Mol... · 0 citations